Brain Cancer & Brain Tumor News Articles |

Brain Cancer News

BRAIN CANCER ADVISOR

Brain Cancer News

Phase 3 Study of Investigative Glioblastoma Tx Halted

AbbVie has halted enrollment in all ongoing studies of depatuxizumab mafodotin, after an Independent Data Monitoring Committee (IDMC) recommended a phase 3 study of the treatment be stopped due to a lack of survival benefit.
Long-term data do not support efficacy of primary temozolomide monotherapy versus radiotherapy in an

Where Have All the T Cells Gone?

New research proposes a novel mechanism for how tumors sidestep the immune system in patients with intracranial tumors.